As of November 6, 2026, KPET Ultra Paceline Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on April 2, 2026 (Form 8-K, April 2, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like KPET Ultra Paceline Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
KPET Ultra Paceline Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-04-02. Every row below is cited to the filing it comes from, and this page adds each new change as KPET Ultra Paceline Corp files it.
Also on the record for KPET Ultra Paceline Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 12, 2026 | Stake report, Schedule 13G, by Adage Capital Management, L.P. | 7.75% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G, by KPThree Capital LLC | 20.2% of the class | 5%+ stakes | Source |
| May 13, 2026 | Stake report, Schedule 13G, by RP Investment Advisors LP | 5.4% of the class | 5%+ stakes | Source |
| April 7, 2026 | Stake report, Schedule 13G, by Sculptor Capital LP | 5.93% of the class | 5%+ stakes | Source |
| April 1, 2026 | IPO filing, Form 424B4 | $10 a share | IPO filings | Source |
| March 24, 2026 | IPO filing, Form S-1/A | — | IPO filings | Source |
| March 5, 2026 | IPO filing, Form S-1 | — | IPO filings | Source |
Selling to them or working with them? See who runs KPET Ultra Paceline Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on KPET Ultra Paceline Corp and the records around it.
KPET Ultra Paceline Corp elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- RP Investment Advisors LP also filed stake reports on 17 other companies: Yorkville International Capital Corp. (Sep 2026), Amanat Acquisition Corp. (Aug 2026), ProCap Acquisition Corp (Aug 2026)
- Sculptor Capital LP also filed stake reports on 40 other companies: Helix Acquisition Corp. III (Oct 2026), Live Oak Acquisition Corp. VI (Oct 2026), Amanat Acquisition Corp (Aug 2026)
- Adage Capital Management, L.P. also filed stake reports on 136 other companies: ACP Holdings Acquisition Corp. (Aug 2026), AmperCap Acquisition Company (Aug 2026), Aura Biosciences, Inc. (Aug 2026)
Watch KPET Ultra Paceline Corp
Get an email when KPET Ultra Paceline Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on KPET Ultra Paceline Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on KPET Ultra Paceline Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on KPET Ultra Paceline Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-04-02 | Reported | not named in the filing | 8-K, 2026-04-02 |
New leaders reset buying decisions — get the Full Report on KPET Ultra Paceline Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at KPET Ultra Paceline Corp, with the record behind each one.
Find candidates like senior executive at KPET Ultra Paceline CorpEvery change, in the filing's words
Reported
On March 30, 2026, Kneeland Youngblood, Kathleen Philips and James McKee were appointed as members of the Board of Directors of the Company (the " Board ").
- The Board has determined that Mr. Youngblood, Ms. Philips and Mr. McKee are "independent directors" as defined in the New York Stock Exchange listing standards and applicable SEC rules.
- Mr. Youngblood, Ms. Philips and Mr. McKee will serve on the audit committee of the Board (the "Audit Committee"), with Ms. Philips serving as chair of the Audit Committee.
- Mr. Youngblood, Ms. Philips and Mr. McKee will serve on the compensation committee, with Mr. Youngblood serving as chair of the compensation committee.
- Each of Mr. Youngblood, Ms. Philips and Mr. McKee purchased 40,000 of the Company's Class B ordinary shares, par value $0.0001 per share (the "Class B Ordinary Shares"), from the Company at their original issue price.
- Concurrently, the Sponsor forfeited and surrendered 120,000 Class B Ordinary Shares to the Company.
- The Company will reimburse its directors for reasonable out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination On March 30, 2026, each of the members of the Board entered into the Letter Agreement and Mr. Youngblood, Ms. Philips and Mr. McKee entered into the Registration Rights Agreement.
Tools for this story
Each opens in a new tab, filled in for KPET Ultra Paceline Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.